Blood
Blood
4 years ago

CD207(+)CD1a(+) cells circulate in pediatric patients with active Langerhans cell histiocytosis.

Olexen CM, Tessone L, Rosso DA, Elena G, Nowak W, Estecho IG, Ortiz Wilczyñski JM, Errasti AE, Carrera Silva EA
Langerhans cell histiocytosis (LCH) is a rare disease with an unknown etiology characterized by heterogeneous lesions containing CD207+CD1a+ cells that can arise in almost any tissue and cause significant morbidity and mortality. Precursors of pathological Langerhans cells have yet to be defined. Our aim was to identify circulating CD207+CD1a+ cells and their inducers in LCH. Expression of CD207 and CD1a in the blood myeloid compartment as well as TSLP and TGFβ plasma levels were measured in 22 pediatric patients with active disease (AD) or non-active disease (NAD). The myeloid compartment showed an increased CD11b (CD11bhigh plus CD11b+) fraction (39.7 ± 3.6 vs 18.6 ± 1.9), a higher percentage of circulating CD11bhighCD11c+CD207+ cells (44.5 ± 11.3 vs 3.2 ± 0.5), and the presence of CD11chighCD207+CD1a+ cells (25.0 ± 9.1 vs 2.3 ± 0.5) in patients with AD vs NAD. Blood CD207+CD1a+ cells were not observed in adult controls or umbilical cord. Increased TSLP and TGFβ levels were detected in patients with AD. Interestingly, plasma from patients with AD induces CD207 expression on CD14+ monocytes. We can conclude that CD207+CD1a+ cells are circulating in patients with active LCH, and TSLP and TGFβ are potential drivers of these LC-like cells in vivo.

Publisher URL: https://www.ncbi.nlm.nih.gov/pubmed/28847997

DOI: PubMed:28847997

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.